Danaher Corporation (NYSE:DHR) Shares Sold by Mather Group LLC.

Mather Group LLC. cut its stake in shares of Danaher Corporation (NYSE:DHR - Free Report) by 66.6% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,184 shares of the conglomerate's stock after selling 6,356 shares during the quarter. Mather Group LLC.'s holdings in Danaher were worth $653,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Heck Capital Advisors LLC bought a new stake in shares of Danaher during the 4th quarter valued at $27,000. GHP Investment Advisors Inc. increased its stake in Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after buying an additional 99 shares in the last quarter. Hurley Capital LLC purchased a new stake in Danaher in the 4th quarter worth $34,000. Rialto Wealth Management LLC purchased a new stake in Danaher in the 4th quarter worth $34,000. Finally, Smallwood Wealth Investment Management LLC purchased a new stake in Danaher in the 1st quarter worth $31,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

DHR has been the subject of a number of analyst reports. Wall Street Zen upgraded Danaher from a "hold" rating to a "buy" rating in a research note on Friday, June 27th. Barclays reissued an "overweight" rating and set a $225.00 price objective (up previously from $215.00) on shares of Danaher in a report on Tuesday, June 24th. TD Cowen increased their price objective on shares of Danaher from $240.00 to $248.00 and gave the company a "buy" rating in a report on Wednesday, April 23rd. JPMorgan Chase & Co. dropped their price target on Danaher from $280.00 to $260.00 and set an "overweight" rating for the company in a research note on Tuesday, April 22nd. Finally, Leerink Partners raised their price target on Danaher from $225.00 to $230.00 and gave the company an "outperform" rating in a report on Wednesday, April 23rd. Four research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company's stock. According to MarketBeat, Danaher currently has an average rating of "Moderate Buy" and an average price target of $248.61.

Danaher Trading Up 0.3%

Shares of NYSE:DHR traded up $0.58 during trading on Friday, reaching $203.08. 1,390,744 shares of the company were exchanged, compared to its average volume of 3,499,704. The business's fifty day simple moving average is $195.63 and its 200-day simple moving average is $207.23. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.43 and a quick ratio of 1.05. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $281.70. The firm has a market capitalization of $145.33 billion, a PE ratio of 39.43, a P/E/G ratio of 2.85 and a beta of 0.77.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, topping the consensus estimate of $1.62 by $0.26. The company had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.58 billion. Danaher had a return on equity of 10.80% and a net margin of 15.81%. On average, research analysts anticipate that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.63%. Danaher's payout ratio is currently 24.85%.

Insider Buying and Selling at Danaher

In other Danaher news, Chairman Steven M. Rales sold 1,250,000 shares of the firm's stock in a transaction on Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the transaction, the chairman directly owned 3,105,808 shares in the company, valued at $611,036,665.92. This trade represents a 28.70% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Christopher Paul Riley sold 15,805 shares of the stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the sale, the executive vice president directly owned 15,179 shares in the company, valued at $3,005,442. This trade represents a 51.01% decrease in their position. The disclosure for this sale can be found here. Company insiders own 11.20% of the company's stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.